Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
- 2019
- Published
An Update on Research- & Bolar exemptions in the U.S. and Europe: Unsolved questions and new developments in an increasingly important area of law
Minssen, Timo & Wested, Jakob, 2019, In: NIR: Nordiskt Immateriellt Rättsskydd. 2, p. 168-183 16 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Editorial
Minssen, Timo & Seitz, C., 2019, In: European Pharmaceutical Law Review. 3, 4, p. 139-141 3 p.Research output: Contribution to journal › Editorial › Research › peer-review
- Published
Medicines authority regulators and industry perspectives on the European regulation of biosimilars
Druedahl, Louise C., De Bruin, M. L. (., van de Weert, Marco, Minssen, Timo, Hoogland, H. & Almarsdóttir, Anna Birna, 2019.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
- Published
Regulating germline editing in assisted reproductive technology: An EU cross-disciplinary perspective
Nordberg, A., Minssen, Timo, Feeney, O., de Miguel Beriain, I., Galvagni, L. & Wartiovaara, K., 2019, In: Bioethics. 34, 1, p. 16-32 16 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The Legal Dimensions of Big Data, Artificial Intelligence and Machine Learning in Pharmaceutical Innovation (original title in accepted version): Editorial to special issue of the European Pharmaceutical Law Review on "Big Data, AI & Machine Learning in Pharmaceutial Innovation"
Minssen, Timo & Seitz, C., 2019, In: European Pharmaceutical Law Review. 3, 4, p. 139-141 3 p.Research output: Contribution to journal › Editorial › Research
- 2018
- Published
AIRR Data Under the E.U. Trade Secrets Directive: Aligning Scientific Practices with Commercial Realities
Sherkow, J. S. & Minssen, Timo, 14 Sep 2018, Social Science Research Network (SSRN), 23 p.Research output: Working paper › Research
- Published
Research- & Bolar exemptions in the U.S. and Europe: Recent developments and possible scenarios: Report on CeBIL webinar III in the webinar series on "Reinterpreting TRIPS in the Life Sciences"
Wested, Jakob & Minssen, Timo, 15 Jul 2018, Social Science Research Network (SSRN). 11 p.Research output: Book/Report › Report › Research
- Published
Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?
Wested, Jakob, Minssen, Timo & Van Zimmeren, E., 13 Jul 2018, In: Life Sciences Intellectual Property Review (LSIPR). 13/7 2018, 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Response to Nuffield Council on Bioethics’ Genome editing and human reproduction: open call for evidence
Nordberg, A., Minssen, Timo, de Miguel Beriain, I., Wartiovaara, K., Galvagni, L. & Feeney, O., 1 Jul 2018, 2 p. Nuffield Council on Bioethics.Research output: Other contribution › Net publication - Internet publication › Research › peer-review
- Published
Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach?
Wested, Jakob, Minssen, Timo & Van Zimmeren, E., Jul 2018, Harvard Law School's Bill of Health blog.Research output: Other contribution › Net publication - Internet publication › Communication
ID: 16150437
Most downloads
-
4329
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2187
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2078
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published